Logo image of WRD

WERIDE INC-ADR (WRD) Stock Fundamental Analysis

USA - NASDAQ:WRD - US9509151083 - ADR

10.19 USD
-0.72 (-6.6%)
Last: 9/26/2025, 8:00:02 PM
10.26 USD
+0.07 (+0.69%)
After Hours: 9/26/2025, 8:00:02 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to WRD. WRD was compared to 81 industry peers in the Automobile Components industry. The financial health of WRD is average, but there are quite some concerns on its profitability. WRD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year WRD has reported negative net income.
WRD Yearly Net Income VS EBIT VS OCF VS FCFWRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -500M -1B -1.5B -2B -2.5B

1.2 Ratios

With a Return On Assets value of -33.96%, WRD is not doing good in the industry: 90.12% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -37.54%, WRD is doing worse than 85.19% of the companies in the same industry.
Industry RankSector Rank
ROA -33.96%
ROE -37.54%
ROIC N/A
ROA(3y)-30.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WRD Yearly ROA, ROE, ROICWRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 40 60 80 100

1.3 Margins

Looking at the Gross Margin, with a value of 28.50%, WRD belongs to the top of the industry, outperforming 86.42% of the companies in the same industry.
WRD's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for WRD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.4%
GM growth 5YN/A
WRD Yearly Profit, Operating, Gross MarginsWRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

4

2. Health

2.1 Basic Checks

WRD does not have a ROIC to compare to the WACC, probably because it is not profitable.
WRD has more shares outstanding than it did 1 year ago.
The debt/assets ratio for WRD is higher compared to a year ago.
WRD Yearly Shares OutstandingWRD Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 50M 100M 150M 200M 250M
WRD Yearly Total Debt VS Total AssetsWRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

WRD has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, WRD belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.39%
WRD Yearly LT Debt VS Equity VS FCFWRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

WRD has a Current Ratio of 11.04. This indicates that WRD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 11.04, WRD belongs to the top of the industry, outperforming 97.53% of the companies in the same industry.
WRD has a Quick Ratio of 10.55. This indicates that WRD is financially healthy and has no problem in meeting its short term obligations.
WRD has a better Quick ratio (10.55) than 97.53% of its industry peers.
Industry RankSector Rank
Current Ratio 11.04
Quick Ratio 10.55
WRD Yearly Current Assets VS Current LiabilitesWRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2B 4B 6B

More info and screens

6

3. Growth

3.1 Past

The earnings per share for WRD have decreased strongly by -26.57% in the last year.
The Revenue for WRD has decreased by -10.13% in the past year. This is quite bad
WRD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.75% yearly.
EPS 1Y (TTM)-26.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.97%
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y37.75%
Revenue growth 5YN/A
Sales Q2Q%-15.02%

3.2 Future

Based on estimates for the next years, WRD will show a very strong growth in Earnings Per Share. The EPS will grow by 28.17% on average per year.
The Revenue is expected to grow by 162.05% on average over the next years. This is a very strong growth
EPS Next Y-8.23%
EPS Next 2Y8.89%
EPS Next 3Y28.17%
EPS Next 5YN/A
Revenue Next Year261.83%
Revenue Next 2Y164.4%
Revenue Next 3Y162.05%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WRD Yearly Revenue VS EstimatesWRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
WRD Yearly EPS VS EstimatesWRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

WRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year WRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WRD Price Earnings VS Forward Price EarningsWRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WRD Per share dataWRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

WRD's earnings are expected to grow with 28.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.89%
EPS Next 3Y28.17%

More info and screens

0

5. Dividend

5.1 Amount

WRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WERIDE INC-ADR

NASDAQ:WRD (9/26/2025, 8:00:02 PM)

After market: 10.26 +0.07 (+0.69%)

10.19

-0.72 (-6.6%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)11-28 2025-11-28
Inst Owners8.3%
Inst Owner Change161.11%
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.80B
Analysts80
Price Target15.12 (48.38%)
Short Float %4.13%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.04%
PT rev (3m)-7.38%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-13.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)143.15%
Revenue NY rev (3m)66.68%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 48.55
P/FCF N/A
P/OCF N/A
P/B 3.08
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)-1.33
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.21
BVpS3.31
TBVpS3.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.96%
ROE -37.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.5%
FCFM N/A
ROA(3y)-30.71%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.4%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.04
Quick Ratio 10.55
Altman-Z N/A
F-ScoreN/A
WACC8.39%
ROIC/WACCN/A
Cap/Depr(3y)101.55%
Cap/Depr(5y)N/A
Cap/Sales(3y)16.18%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.97%
EPS Next Y-8.23%
EPS Next 2Y8.89%
EPS Next 3Y28.17%
EPS Next 5YN/A
Revenue 1Y (TTM)-10.13%
Revenue growth 3Y37.75%
Revenue growth 5YN/A
Sales Q2Q%-15.02%
Revenue Next Year261.83%
Revenue Next 2Y164.4%
Revenue Next 3Y162.05%
Revenue Next 5YN/A
EBIT growth 1Y-39.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.98%
EBIT Next 3Y28.93%
EBIT Next 5YN/A
FCF growth 1Y-32.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25%
OCF growth 3YN/A
OCF growth 5YN/A